Top of page
Health

Cystic fibrosis Orkambi drug will ‘transform lives’ of young people

Colorful pills and capsules

The lives of young people with cystic fibrosis will be “transformed” by a life-extending drug approved to treat the condition, campaigners have said.

Earlier this month , the Department of Health confirmed its intention to make Orkambi available in Northern Ireland. It improves lung function in those with cystic fibrosis – a life-shortening genetic condition that can cause fatal lung damage.

Approximately one in 2,500 babies born in the UK has cystic fibrosis. Only about half of those with the condition live to the age of 32.

Orkambi does not work for all patients, but two other drugs to treat cystic fibrosis symptoms, Symkevi and Kalydeco, will also be made available in Northern Ireland.

Symkevi is restricted to over 12-year-olds, while Kalydeco can be used from 12 months. Families have campaigned for Orkambi since 2015, when it was licensed to treat certain cystic fibrosis patients.

The drug can be given to children as young as two.The drug, which costs approximately £104,000 a year per patient, was deemed too expensive by the health advisory body, NICE.

Cystic fibrosis is an inherited condition in which the lungs and digestive system can become clogged with thick, sticky mucus. It can cause problems with breathing and digestion from a young age.

You might also like

A disabled girl being lifted into a wheelchair with help from a special lift operated by a care assistant. A disabled girl being lifted into a wheelchair with help from a special lift operated by a care assistant.

12,000 people in UK become unpaid carers every day

Around 12,000 people become unpaid carers every day in the…

Alzheimer's Patient Alzheimer's Patient

Aged care collapsing as phase two of pay case kicks off

Aged care collapsing as phase two of pay case kicks…

Nurse talking with patient in wheelchair Nurse talking with patient in wheelchair

Enrollment and eligibility for Medicare for people with disabilities

Medicare is a government program designed to provide medical coverage…

microscopic photo of coronavirus microscopic photo of coronavirus

More caution in health services as cases rise

NSW Health has upgraded its COVID-19 risk rating to amber…